Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BCAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HSD17B14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGF21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FUT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IZUMO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R15A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TULP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAMSTR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FUT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUCB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NTN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on